Outcome of CO2 laser vaporization for oral potentially malignant disorders treatment

Oral Cancer and Oral Potentially Malignant Disorders

CO2 lasers in the management of potentially malignant and malignant oral disorders

The CO2 laser was invented in 1963 by Kumar Patel. Since the early 1970s, CO2 laser has proved to be an effective method of treatment for patients with several types of oral lesions, including early squamous cell carcinoma.Laser surgery of oral premalignant disorders is an effective tool in a complete management strategy which includes careful clinical follow-up, patient education to eliminate ...

Oral potentially malignant disorders: Is malignant transformation predictable and preventable?

Leukoplakia is the most common potentially malignant disorder of the oral mucosa. The prevalence is approximately 1% while the annual malignant transformation ranges from 2% to 3%. At present, there are no reliable clinicopathological or molecular predicting factors of malignant transformation that can be used in an individual patient and such event can not truly be prevented. Furthermore, foll...

efficacy of diode laser for the management of potentially malignant disorders

introduction: laser dentistry is a one of the upcoming advanced treatment modality for oral mucosal lesions. diode laser is a soft tissue laser that has found much acceptance in all branches of dentistry. available compact size and feasibility has render diode laser an enhanced tool for today’s clinical practice. the aim of this study is to determine the efficacy and safety of diode laser for t...

quantitative immunoexpression of egfr in oral potentially malignant disorders: oral leukoplakia and oral submucous fibrosis

background and aims. many oral squamous cell carcinomas develop from potentially malignant disorders (pmds) which include a variety of lesions and conditions characterized by an increased risk for malignant transformation. this study evaluated the quantitative expression of egfr in normal oral mucosa, oral leukoplakia and oral submucous fibrosis to predict the malignant risk in compliance with ...